EE+ POEM Archive
Men who take terazosin, doxazosin, or alfuzosin rather than tamsulosin or 5α-reductase inhibitors are less likely to develop Lewy body dementia
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Men Who Take Terazosin, Doxazosin, or Alfuzosin Rather Than Tamsulosin or 5α-reductase Inhibitors Are Less Likely to Develop Lewy Body Dementia." EE+ POEM Archive, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377178/all/Men_who_take_terazosin__doxazosin__or_alfuzosin_rather_than_tamsulosin_or_5α_reductase_inhibitors_are_less_likely_to_develop_Lewy_body_dementia.
Men who take terazosin, doxazosin, or alfuzosin rather than tamsulosin or 5α-reductase inhibitors are less likely to develop Lewy body dementia. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377178/all/Men_who_take_terazosin__doxazosin__or_alfuzosin_rather_than_tamsulosin_or_5α_reductase_inhibitors_are_less_likely_to_develop_Lewy_body_dementia. Accessed January 16, 2025.
Men who take terazosin, doxazosin, or alfuzosin rather than tamsulosin or 5α-reductase inhibitors are less likely to develop Lewy body dementia. (2025). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377178/all/Men_who_take_terazosin__doxazosin__or_alfuzosin_rather_than_tamsulosin_or_5α_reductase_inhibitors_are_less_likely_to_develop_Lewy_body_dementia
Men Who Take Terazosin, Doxazosin, or Alfuzosin Rather Than Tamsulosin or 5α-reductase Inhibitors Are Less Likely to Develop Lewy Body Dementia [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2025. [cited 2025 January 16]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377178/all/Men_who_take_terazosin__doxazosin__or_alfuzosin_rather_than_tamsulosin_or_5α_reductase_inhibitors_are_less_likely_to_develop_Lewy_body_dementia.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Men who take terazosin, doxazosin, or alfuzosin rather than tamsulosin or 5α-reductase inhibitors are less likely to develop Lewy body dementia
ID - 3377178
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377178/all/Men_who_take_terazosin__doxazosin__or_alfuzosin_rather_than_tamsulosin_or_5α_reductase_inhibitors_are_less_likely_to_develop_Lewy_body_dementia
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
